207560749	207560749	CD	B-NP	O
|	|	NNP	I-NP	O
JH	JH	NNP	I-NP	O
|	|	VBD	B-VP	O
46499404	46499404	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6067546	6067546	CD	B-NP	O
|	|	CC	I-NP	O
7/29/2006	7/29/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Tracheobronchitis	Tracheobronchitis	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/4/2006	5/4/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/14/2006	5/14/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
YORIO	YORIO	NNP	B-NP	O
,	,	,	O	O
TROY	TROY	NNP	B-NP	O
J	J	NNP	I-NP	O
973-32-08-7	973-32-08-7	CD	I-NP	O
Ra	Ra	NNP	I-NP	O
Montport	Montport	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
5/17/06	5/17/06	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
CONTINGENT	CONTINGENT	JJ	B-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HUMPHREY	HUMPHREY	NNP	B-NP	O
,	,	,	O	O
BOB	BOB	NNP	B-NP	O
ROBERTO	ROBERTO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/27/06	5/27/06	CD	B-NP	O
by	by	IN	B-PP	O
GUBIN	GUBIN	NNP	B-NP	B-protein
,	,	,	O	O
JAYSON	JAYSON	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
870018061	870018061	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/28/06	6/28/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TESSALON	TESSALON	NN	I-NP	O
PERLES	PERLES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BENZONATATE	BENZONATATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
cough	cough	IN	B-PP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FLONASE	FLONASE	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FLUTICASONE	FLUTICASONE	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
FLOVENT	FLOVENT	NN	I-NP	O
HFA	HFA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
88	88	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/27/06	5/27/06	CD	B-NP	O
by	by	IN	B-PP	O
VERHEY	VERHEY	NNP	B-NP	O
,	,	,	O	O
ELISHA	ELISHA	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
meds	med	NNS	I-NP	O
GLYBURIDE	GLYBURIDE	NN	I-NP	B-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
GUAIFENESIN	GUAIFENESIN	NN	I-NP	I-protein
DM	DM	NN	I-NP	O
5	5	CD	B-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
cough	cough	NN	B-NP	O
HYDROXYZINE	HYDROXYZINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
Oversedation	Oversedation	NNP	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
18	18	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
Last	Last	JJ	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
<	<	SYM	B-NP	O
75	75	CD	B-NP	O
.	.	.	O	O

ISOSORBIDE	ISOSORBIDE	NN	B-NP	B-protein
MONONITRATE	MONONITRATE	NN	I-NP	I-protein
60	60	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
HR	HR	NN	B-NP	B-protein
<	<	SYM	B-ADJP	I-protein
50	50	CD	B-NP	I-protein
,	,	,	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
95	95	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
LOSARTAN	LOSARTAN	NN	I-NP	O
50	50	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
METFORMIN	METFORMIN	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
HR	HR	NN	B-NP	B-protein
<	<	SYM	O	I-protein
55	55	CD	B-NP	I-protein
,	,	,	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Follow-up	Follow-up	NNP	B-NP	O
with	with	IN	B-PP	O
Er	Er	NNP	B-NP	B-protein
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Horace	Horace	NNP	B-NP	O
Mccutchan	Mccutchan	NNP	I-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Cephalosporins	Cephalosporin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
rule	rule	NN	B-VP	O
out	out	RP	B-PRT	O
PE	PE	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Tracheobronchitis	Tracheobronchitis	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
MI	MI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
angioplasty	angioplasty	JJ	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DM	DM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
prostate	prostate	NN	I-NP	O
ca	ca	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
prostate	prostate	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
in-stent	in-stent	JJ	I-NP	O
restenosis	restenosis	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PFTs	PFTs	NNP	I-NP	O
PE	PE	NNP	I-NP	O
Protocol	Protocol	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
CT	CT	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
****************************	****************************	SYM	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
76M	76M	NN	B-NP	O
hx/o	hx/o	NN	I-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
who	who	WP	B-NP	O
p/w	p/w	VBP	B-VP	O
2	2	CD	B-NP	O
wk	wk	NN	I-NP	O
hx/o	hx/o	NN	I-NP	O
incr	incr	NN	I-NP	O
DOE	DOE	NNP	I-NP	O
,	,	,	O	O
incr	incr	NN	B-NP	O
fatigue	fatigue	NN	I-NP	O
,	,	,	O	O
incr	incr	NN	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADJP	O
productive	productive	JJ	I-ADJP	O
of	of	IN	B-PP	O
yellow	yellow	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
c	c	NN	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
e-mycin	e-mycin	NN	B-NP	O
.	.	.	O	O

Cough	Cough	NN	B-NP	O
,	,	,	I-NP	O
discomfort	discomfort	NN	I-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
persisted	persist	VBD	B-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
chlls	chll	NNS	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
sweats	sweat	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
wt	wt	NN	B-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
is	be	VBZ	B-VP	O
174lbs	174lb	NNS	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
MD	MD	NN	B-NP	B-protein
office	office	NN	I-NP	I-protein
178lbs	178lb	NNS	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
LE	LE	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

2-pillow	2-pillow	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
now	now	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
.	.	.	O	O

Called	Call	VBN	B-VP	O
Iside	Iside	NNP	B-NP	O
Health	Health	NNP	I-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	O
no	no	DT	B-NP	O
callback	callback	NN	I-NP	O
so	so	RB	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
hospital	hospital	NN	B-NP	O
for	for	IN	B-PP	O
rule	rule	NN	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
cause	cause	NN	I-NP	O
for	for	IN	B-PP	O
sxs	sx	NNS	B-NP	O
.	.	.	O	O

Took	Took	NNP	B-NP	O
lasix	lasix	CD	I-NP	O
po	po	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
to	to	TO	B-PP	O
ED	ED	NN	B-NP	O
In	In	IN	B-PP	O
PMHO	PMHO	NN	B-NP	O
ED	ED	NN	I-NP	O
:	:	:	O	O
Rcv	Rcv	NN	B-NP	B-protein
'd	'd	POS	B-NP	O
additional	additional	JJ	I-NP	O
40mg	40mg	NN	I-NP	O
IV	IV	CD	I-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	I-NP	O
combivent	combivent	JJ	I-NP	O
,	,	,	I-NP	O
albuterol	albuterol	NN	I-NP	O
c	c	NN	I-NP	O
resultant	resultant	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
sxs	sx	NNS	B-NP	O
.	.	.	O	O

D-dimer	D-dimer	NN	B-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
1750	1750	CD	B-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
prior	prior	RB	B-ADVP	O
at	at	IN	B-PP	O
106	106	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
biomarkers	biomarker	NNS	I-NP	I-protein
negative	negative	JJ	B-NP	I-protein
x	x	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
otherwise	otherwise	RB	B-ADJP	O
unremarkable	unremarkable	JJ	I-ADJP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
neg	neg	NN	B-NP	O
.	.	.	O	O

********************	********************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
:	:	:	O	O
IMI	IMI	NN	B-NP	O
1970	1970	CD	I-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
subsequent	subsequent	JJ	I-NP	O
non-Q	non-Q	JJ	I-NP	O
wave	wave	NN	I-NP	O
MIs	MI	NNS	I-NP	O
1970s	1970s	CD	B-NP	O
,	,	,	O	O
CABG	CABG	NNP	B-NP	B-protein
'74	'74	CD	I-NP	I-protein
,	,	,	O	O
'	'	''	O	O
82	82	CD	B-NP	O
.	.	.	O	O

Cath	Cath	NN	B-NP	O
9/27	9/27	CD	I-NP	O
c	c	NN	I-NP	O
patent	patent	NN	I-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
occluded	occlude	VBD	B-VP	O
SV	SV	NN	B-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
OM	OM	NN	B-NP	O
and	and	CC	O	O
occluded	occlude	VBD	B-VP	O
SV	SV	NN	B-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
.	.	.	O	O

PCI	PCI	NN	B-NP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
main	main	JJ	B-ADJP	O
in	in	IN	B-PP	O
ramus	ramus	NN	B-NP	O
.	.	.	O	O

Cath	Cath	NN	B-NP	O
9/18	9/18	CD	I-NP	O
PTCA	PTCA	NN	I-NP	O
and	and	CC	I-NP	O
brachytherapy	brachytherapy	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
main	main	JJ	I-NP	O
stent	stent	NN	I-NP	O
;	;	:	O	O
Ischemic	Ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
-	-	HYPH	B-NP	O
LVEF	LVEF	NN	I-NP	B-protein
=	=	SYM	B-VP	O
33	33	CD	B-NP	O
%	%	NN	I-NP	O
by	by	IN	B-PP	O
MIBI	MIBI	NNP	B-NP	O
3/06	3/06	CD	I-NP	O
,	,	,	O	O
DM2	DM2	NN	B-NP	B-protein
,	,	,	O	O
Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
,	,	,	O	O
Obesity	Obesity	NN	B-NP	O
,	,	,	O	O
Pros	Pros	NN	B-NP	B-protein
ca	ca	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
radiation	radiation	NN	I-NP	I-protein
therapy	therapy	NN	I-NP	I-protein
8/06	8/06	CD	I-NP	I-protein
,	,	,	O	O
GIB	GIB	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
ICD/pacemaker	ICD/pacemaker	NN	I-NP	O
implantation	implantation	NN	I-NP	O
for	for	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Syncope	Syncope	NN	B-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	B-protein
,	,	,	O	O
Subclavian	Subclavian	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
s/p	s/p	NN	I-NP	O
PCI	PCI	NN	I-NP	O
4/3	4/3	CD	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CEA	CEA	NNP	I-NP	O
,	,	,	O	O
Hypothyroidism	Hypothyroidism	NNP	B-NP	O
**************************************************	**************************************************	SYM	I-NP	O
MEDICATIONS	MEDICATIONS	NN	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
20qd	20qd	VBD	B-VP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Gemfibrozil	Gemfibrozil	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
Mon	Mon	NNP	I-NP	O
+	+	SYM	I-NP	O
Thurs	Thur	NNPS	I-NP	O
,	,	,	O	O
Metoprolol	Metoprolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
,	,	,	O	O
Amiodarone	Amiodarone	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Glyburide	Glyburide	NN	B-NP	O
10mg	10mg	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Metformin	Metformin	NN	B-NP	O
1000	1000	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
?	?	.	O	O

Dose	Dose	NNP	B-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Hydroxyzine	Hydroxyzine	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
,	,	,	O	O
SLNTG	SLNTG	NN	B-NP	O
prn	prn	NN	I-NP	O
ALLERGIES/SENSITIVITIES	ALLERGIES/SENSITIVITIES	NN	I-NP	O
:	:	:	O	O
KEFLEX	KEFLEX	NN	B-NP	O
FAMILY	FAMILY	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Father	Father	NNP	B-NP	O
had	have	VBD	B-VP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

******************	******************	SYM	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
GENERAL	GENERAL	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
.	.	.	O	O

Voice	Voice	NNP	B-NP	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
horse	horse	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
coughing	cough	VBG	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
since	since	IN	B-PP	O
admission	admission	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
still	still	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
moist	moist	NN	I-NP	O
sounding	sounding	JJ	I-NP	O
cough	cough	NN	I-NP	O
occasionally	occasionally	RB	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
LUNGS	LUNGS	NN	I-NP	O
:	:	:	O	O
Bilateral	Bilateral	JJ	B-NP	O
Rales/moist	Rales/moist	NN	I-NP	O
wheezes/tracheobronchial	wheezes/tracheobronchial	JJ	I-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Much	Much	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-ADJP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
s2	s2	NN	I-NP	I-protein
,	,	,	O	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
Abdomen	Abdoman	NNS	I-NP	O
:	:	:	O	O
S/NT/ND	S/NT/ND	NN	B-NP	O
+	+	SYM	O	O
BS	BS	NNP	B-NP	O
Extremities	Extremity	NNPS	I-NP	O
:	:	:	O	O
WWP	WWP	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
peripheral	peripheral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
******************	******************	SYM	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
1.2	1.2	CD	I-NP	O
,	,	,	O	O
K	K	NNP	B-NP	O
4.6	4.6	NNP	I-NP	O
,	,	,	O	O
Glc	Glc	NNP	B-NP	O
127	127	CD	I-NP	O
,	,	,	O	O
Lactate	Lactate	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
D-dimer	D-dimer	NN	B-NP	O
1751	1751	CD	I-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
CP	CP	NN	I-NP	O
process	process	NN	I-NP	O
PE	PE	NN	I-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

PFTS	PFTS	NNS	B-NP	O
:	:	:	O	O
FVC	FVC	NN	B-NP	O
=	=	SYM	B-VP	O
1.4	1.4	CD	B-NP	O
-LRB-	-LRB-	SYM	O	O
48	48	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
FEV1	FEV1	NN	I-NP	O
=	=	SYM	B-VP	O
1.02	1.02	CD	B-NP	O
-LRB-	-LRB-	SYM	O	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
FEV1/FVC	FEV1/FVC	NN	B-NP	O
=	=	SYM	B-VP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
predicted	predict	VBN	B-VP	O
TLC	TLC	NN	B-NP	O
=	=	SYM	B-VP	O
3.19	3.19	CD	B-NP	O
-LRB-	-LRB-	SYM	O	O
61	61	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
inhaler	inhaler	NN	I-NP	O
trial	trial	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
albuterol	albuterol	NN	B-NP	O
usage	usage	NN	I-NP	O
2	2	CD	B-NP	O
hrs	hr	NNS	I-NP	O
prior	prior	JJ	B-NP	O
******************	******************	SYM	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Troponin	Troponin	NN	B-NP	B-protein
negative	negative	JJ	I-NP	I-protein
x	x	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

Index	Index	NN	B-NP	O
of	of	IN	B-PP	O
suspicion	suspicion	NN	B-NP	O
low	low	JJ	B-ADJP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
coughing	cough	VBG	I-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
antihypertensives	antihypertensive	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
EF	EF	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	O
@	@	NN	I-NP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
=	=	SYM	B-VP	O
102	102	CD	B-NP	O
-LRB-	-LRB-	SYM	B-VP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
last	last	JJ	B-NP	O
admission	admission	NN	I-NP	O
when	when	WRB	B-ADVP	O
symptomatic	symptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Returned	Return	VBN	B-VP	O
to	to	TO	B-VP	O
home	home	VB	I-VP	O
diuretic	diuretic	JJ	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

D/C	D/C	NN	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
and	and	CC	O	O
begin	begin	VB	B-VP	O
losartan	losartan	NN	B-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
captopril	captopril	NN	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
Maintained	Maintain	VBN	B-VP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
.	.	.	O	O

Paced	Pace	VBN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulm	Pulm	NNP	B-NP	O
:	:	:	O	O
Believe	Believe	NNP	B-NP	O
cough	cough	NN	I-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
tracheobronchitis	tracheobronchitis	NN	B-NP	O
vs	vs	IN	B-PP	O
post	post	NN	B-NP	O
infectious	infectious	JJ	I-NP	O
tussive	tussive	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

PFTs	PFT	NNS	B-NP	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Provided	Provide	VBN	B-NP	O
tessalon	tessalon	NN	I-NP	O
perles	perle	NNS	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pt	pt	NN	I-NP	O
,	,	,	O	O
duonebs	duoneb	NNS	B-NP	O
.	.	.	O	O

Completed	Complete	VBN	B-NP	O
5d	5d	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
azithro	azithro	NN	B-NP	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
c/s	c/	NNS	I-NP	O
involved	involve	VBD	B-VP	O
c	c	NN	B-NP	O
recs	rec	NNS	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
sputum	sputum	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
oral	oral	JJ	I-NP	I-protein
flora	flora	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
flovent	flovent	NN	B-NP	O
,	,	,	O	O
flonase	flonase	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
PRN	PRN	NN	B-NP	O
albuterol	albuterol	NN	I-NP	O
inhaler	inhaler	NN	I-NP	O
-	-	HYPH	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Jared	Jared	NNP	B-NP	O
Childress	Childress	NNP	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Elev	Elev	NNP	B-NP	O
Cr	Cr	NNP	I-NP	O
to	to	TO	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

Restarted	Restart	VBN	B-NP	O
lasix	lasix	NN	I-NP	O
during	during	IN	B-PP	O
hosp	hosp	NN	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
appears	appear	VBZ	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
Maintained	Maintained	NNP	B-NP	O
K	K	NNP	I-NP	O
&	&	CC	I-NP	O
Mg	Mg	NNP	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
received	receive	VBD	B-VP	O
diabetic	diabetic	JJ	B-NP	O
,	,	,	I-NP	O
sodium	sodium	NN	I-NP	O
restricted	restricted	JJ	I-NP	O
,	,	,	O	O
fluid	fluid	NN	B-NP	O
restricted	restricted	JJ	I-NP	O
,	,	,	I-NP	O
low	low	JJ	I-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

Continue	Continue	VB	B-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
them	them	PRP	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
additions	addition	NNS	I-NP	O
:	:	:	O	O
Tessalon	Tessalon	NNP	B-NP	O
Perrles	Perrles	NNP	I-NP	O
and	and	CC	I-NP	O
Guaifenasin	Guaifenasin	NNP	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
cough	cough	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
medication	medication	NN	I-NP	O
list	list	NN	I-NP	O
-	-	HYPH	O	O
Flovent	Flovent	NN	B-NP	O
,	,	,	O	O
Flonase	Flonase	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
alubeterol	alubeterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
need	need	VBP	B-VP	O
it	it	PRP	B-NP	O
for	for	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
or	or	CC	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
contact	contact	VB	I-VP	O
your	your	PRP$	B-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
fever	fever	RB	B-ADVP	O
to	to	TO	B-PP	O
>	>	SYM	B-NP	O
101	101	CD	I-NP	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
contact	contact	VB	I-VP	O
your	your	PRP$	B-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	O	O
Check	Check	NNP	B-NP	O
Creatinine	Creatinine	NNP	I-NP	O
-	-	HYPH	B-NP	O
Follow	Follow	NNP	I-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
adjust	adjust	JJ	B-NP	O
diuretics	diuretic	NNS	I-NP	O
-	-	HYPH	B-NP	O
Assess	Assess	NN	I-NP	O
cough	cough	NN	I-NP	O
and	and	CC	O	O
provide	provide	VBP	B-VP	O
additional	additional	JJ	B-NP	O
cough	cough	NN	I-NP	O
suppresants	suppresant	NNS	I-NP	O
pRN	pRN	NN	I-NP	O
-	-	HYPH	B-NP	O
WBC	WBC	NN	I-NP	O
shoudl	shoudl	NN	I-NP	O
decr	decr	NN	I-NP	O
c	c	NN	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
TERCERO	TERCERO	NNP	B-NP	O
,	,	,	O	O
BOYCE	BOYCE	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LR29	LR29	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/28/06	6/28/06	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
18	18	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

